» Articles » PMID: 10051147

Selective Effects of a 4-oxystilbene Derivative on Wild and Mutant Neuronal Chick Alpha7 Nicotinic Receptor

Overview
Journal Br J Pharmacol
Publisher Wiley
Specialty Pharmacology
Date 1999 Mar 2
PMID 10051147
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

1. We assessed the pharmacological activity of triethyl-(beta-4-stilbenoxy-ethyl) ammonium (MG624), a drug that is active on neuronal nicotinic receptors (nicotinic AChR). Experiments on the major nicotinic AChR subtypes present in chick brain, showed that it inhibits the binding of [125I]-alphaBungarotoxin (alphaBgtx) to the alpha7 subtype, and that of [3H]-epibatidine (Epi) to the alpha4beta2 subtype, with Ki values of respectively 106 nM and 84 microM. 2. MG624 also inhibited ACh elicited currents (I(ACh)) in the oocyte-expressed alpha7 and alpha4beta2 chick subtypes with half-inhibitory concentrations (IC50) of respectively 109 nM and 3.2 microM. 3. When tested on muscle-type AChR, it inhibited [125I]-alphaBgtx binding with a Ki of 32 microM and ACh elicited currents (I(ACh)) in the oocyte-expressed alpha1beta1gammadelta chick subtype with an IC50 of 2.9 microM. 4. The interaction of MG624 with the alpha7 subtype was investigated using an alpha7 homomeric mutant receptor with a threonine-for-leucine 247 substitution (L247T alpha7). MG624 did not induce any current in oocytes expressing the wild type alpha7 receptor, but did induce large currents in the oocyte-expressed L247T alpha7 receptor. The MG624 elicited current (I(MG62)) has an EC50 of 0.2 nM and a Hill coefficient nH of 1.9, and is blocked by the nicotinic receptor antagonist methyllycaconitine (MLA). 5. These binding and electrophysiological studies show that MG624 is a potent antagonist of neuronal chick alpha7 nicotinic AChR, and becomes a competitive agonist following the mutation of the highly conserved leucine residue 247 located in the M2 channel domain.

Citing Articles

Targeting Alpha7 Nicotinic Acetylcholine Receptors in Lung Cancer: Insights, Challenges, and Therapeutic Strategies.

Arunrungvichian K, Vajragupta O, Hayakawa Y, Pongrakhananon V ACS Pharmacol Transl Sci. 2024; 7(1):28-41.

PMID: 38230275 PMC: 10789132. DOI: 10.1021/acsptsci.3c00138.


Assessment of α7 nicotinic acetylcholine receptor availability in juvenile pig brain with [¹⁸F]NS10743.

Deuther-Conrad W, Fischer S, Hiller A, Becker G, Cumming P, Xiong G Eur J Nucl Med Mol Imaging. 2011; 38(8):1541-9.

PMID: 21484373 DOI: 10.1007/s00259-011-1808-y.


Role of channel activation in cognitive enhancement mediated by alpha7 nicotinic acetylcholine receptors.

Briggs C, Gronlien J, Curzon P, Timmermann D, Ween H, Thorin-Hagene K Br J Pharmacol. 2009; 158(6):1486-94.

PMID: 19845675 PMC: 2795215. DOI: 10.1111/j.1476-5381.2009.00426.x.


Cholinergic regulation of epithelial ion transport in the mammalian intestine.

Hirota C, McKay D Br J Pharmacol. 2006; 149(5):463-79.

PMID: 16981004 PMC: 2014671. DOI: 10.1038/sj.bjp.0706889.


Combining the use of solid-supported transition metal catalysis with microwave irradiation in solution-phase parallel library synthesis.

Organ M, Mayer S, Lepifre F, NZemba B, Khatri J Mol Divers. 2004; 7(2-4):211-27.

PMID: 14870853 DOI: 10.1023/b:modi.0000006826.91512.83.


References
1.
Anand R, Peng X, Lindstrom J . Homomeric and native alpha 7 acetylcholine receptors exhibit remarkably similar but non-identical pharmacological properties, suggesting that the native receptor is a heteromeric protein complex. FEBS Lett. 1993; 327(2):241-6. DOI: 10.1016/0014-5793(93)80177-v. View

2.
Vernallis A, Conroy W, Berg D . Neurons assemble acetylcholine receptors with as many as three kinds of subunits while maintaining subunit segregation among receptor subtypes. Neuron. 1993; 10(3):451-64. DOI: 10.1016/0896-6273(93)90333-m. View

3.
Dani J, Heinemann S . Molecular and cellular aspects of nicotine abuse. Neuron. 1996; 16(5):905-8. DOI: 10.1016/s0896-6273(00)80112-9. View

4.
Gerzanich V, Peng X, Wang F, Wells G, Anand R, Fletcher S . Comparative pharmacology of epibatidine: a potent agonist for neuronal nicotinic acetylcholine receptors. Mol Pharmacol. 1995; 48(4):774-82. View

5.
Ward J, Cockcroft V, Lunt G, Smillie F, Wonnacott S . Methyllycaconitine: a selective probe for neuronal alpha-bungarotoxin binding sites. FEBS Lett. 1990; 270(1-2):45-8. DOI: 10.1016/0014-5793(90)81231-c. View